Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation
Hypertrophic cardiomyopathy (HCM) is characterized by heterogeneous clinical expression. Cardiac transplantation continues to be the gold standard for the treatment of end-stage cardiac diseases refractory to medical therapy. We presented a 27-year-old female patient with HCM who underwent successfu...
Saved in:
Main Authors: | Ahmet Vural (Author), Gökhan Ertaş (Author), Ayşen Ağaçdiken (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2013-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiac resynchronization therapy in a case with single ventricle and concommitant noncompaction cardiomyopathy
by: Deniz Elçik, et al.
Published: (2020) -
Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
by: Arda Şanlı Ökmen, et al.
Published: (2013) -
Influences of cardiac resynchronization therapy on cardiac biomarkers in patients with chronic heart failure
by: Yüksel Çavuşoğlu
Published: (2018) -
Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
by: Permsuwan U, et al.
Published: (2020) -
Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
by: M. S. Bychkova, et al.
Published: (2023)